000			01864 a2200529 4500
005			20250515074532.0
264		0	_c20091203
008			200912s 0 0 eng d
022			_a1479-5876
024	7		_a10.1186/1479-5876-5-38 _2doi
040			_aNLM _beng _cNLM
100	1		_aMangiameli, David P
245	0	0	_aCombination therapy targeting the tumor microenvironment is effective in a model of human ocular melanoma. _h[electronic resource]
260			_bJournal of translational medicine _cJul 2007
300			_a38 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aBenzenesulfonates _xtherapeutic use
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aEndothelial Cells _xdrug effects
650	0	4	_aEye Neoplasms _xblood supply
650	0	4	_aHumans
650	0	4	_aIn Vitro Techniques
650	0	4	_aLenalidomide
650	0	4	_aMelanoma _xblood supply
650	0	4	_aNeovascularization, Pathologic _xdrug therapy
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSorafenib
650	0	4	_aThalidomide _xanalogs & derivatives
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aBlansfield, Joseph A
700	1		_aKachala, Stephan
700	1		_aLorang, Dominique
700	1		_aSchafer, Peter H
700	1		_aMuller, George W
700	1		_aStirling, David I
700	1		_aLibutti, Steven K
773	0		_tJournal of translational medicine _gvol. 5 _gp. 38
856	4	0	_uhttps://doi.org/10.1186/1479-5876-5-38 _zAvailable from publisher's website
999			_c17174664 _d17174664